1. SGLT2 inhibitors may lower gout risk  Healio
  2. Diabetes Drug Class May Hold Promise for Gout Prevention  Medscape
  3. View full coverage on Google News
Among patients with type 2 diabetes, using SGLT2 inhibitors may lower the risk for gout compared with other antidiabetic medications, according to study findings published in the Annals of Internal Medicine. “Over 10 million adults across North America have gout,” Michael Fralick, MD, PhD, SM, FRCPC, a general internist at Sinai Health in Toronto and affiliated faculty member in the Among patients with type 2 diabetes, using SGLT2 inhibitors may lower the risk for gout compared with other antidiabetic medications, according to study findings published in the Annals of Internal Medicine. “Over 10 million adults across North America have gout,” Michael Fralick, MD, PhD, SM, FRCPC, a general internist at Sinai Health in Toronto and affiliated faculty member in the

SGLT2 inhibitors may lower gout risk

Adults with type 2 diabetes prescribed an SGLT2 inhibitor were less likely to develop gout than those prescribed a GLP-1 receptor agonist.Adults with type 2 diabetes prescribed an SGLT2 inhibitor were less likely to develop gout than those prescribed a GLP-1 receptor agonist.

Diabetes Drug Class May Hold Promise for Gout Prevention